NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-257-2005-0-CH-07 Wide-area Fluorescence Detection System For Two-photon Microscopy CH EP 07811119.2 Issued
NHLBI E-257-2005-0-GB-10 Wide-area Fluorescence Detection System For Two-photon Microscopy GB EP 07811119.2 Issued
NHLBI E-257-2005-0-PCT-02 Wide-area Fluorescence Detection System For Two-photon Microscopy PCT PCT PCT/US2007/17478 Expired
NCI E-099-1989-0-US-30 METHODS FOR IDENTIFYING ALPHA PDGFR AGONISTS AND ANTAGONISTS US DIV 11/834,541 Abandoned
NHLBI E-257-2005-0-AU-06 Wide-area Fluorescence Detection System For Two-photon Microscopy AU National Stage 2007281902 Abandoned
NIAID E-089-1997-2-AU-13 PRODUCTION OF ATTENTUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES AU DIV 2007203671 Abandoned
NICHD E-181-2004-0-US-07 NANDROLONE 17B-CARBONATES US National Stage 11/815,532 7820642 Issued PDF
NIAID E-270-2004-0-JP-04 Method to Predict and Prevent Oxygen-Induced Inflammatory Tissue Injury JP National Stage 2007-554143 Abandoned
NCI E-150-2007-0-US-01 COMPOSITIONS AND METHODS FOR TREATING PIGMENTARY CONDITIONS AND MELANOMA US 60/963,280 Abandoned
NINDS E-002-2009-0-US-01 Use Of Phosphatases To Treat Neuroblastomas And Medulloblastomas US 60/963,307 Abandoned
NCI E-085-2003-2-US-09 Cyanoviran Variant-Polymer Conjugates US DIV 11/832,925 7547509 Expired PDF
NIAID E-289-2007-0-US-01 Methods for Detecting and Prevention of Tick Infestation and Pathogen Transmission US 60/963,332 Abandoned
NCI E-103-2005-3-CA-03 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies CA National Stage 2596698 Expired
NCI E-297-2007-0-US-01 Differentiation-induction And Chemosensitizing Therapy Of Cancer Using Tissue Inhibitor Of Matrix Metalloproteinases-2 (TIMP-2) Mutants And Peptides US 60/953,352 Abandoned
NIMH E-268-2007-0-US-01 A Fold-back Diabody Format For Diptheria Toxin Based Immunotoxins That Can Increase Binding And Potentcy With Particular Application To An Anti-prostratic Cancer Immunotoxin A-dmDT390scfbDb(591) US 60/953,416 Abandoned
NIDCR E-268-2002-0-US-03 RECOMBINANT MODIFIED BACILLUS ANTHRACIS PROTECTIVE ANTIGEN FOR USE IN VACCINES US DIV 11/831,860 8394387 Issued PDF
NIEHS E-103-2000-3-PCT-02 Biologically Potent Analogues of the Dmt-Tic Pharmocophore And Methods of Use PCT PCT PCT/US07/074839 Expired
NIAID E-161-2007-0-US-01 Treatment Of Primary Tumors And Tumor Metastases With TNF-alpha Antagonists US 60/962,668 Abandoned
NCI E-078-2006-0-EP-05 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR EP National Stage 07813497.0 Abandoned
NCI E-078-2006-0-GB-09 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR GB EP 07813497.0 Abandoned
NCI E-078-2006-0-FR-08 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR FR EP 07813497.0 Abandoned
NCI E-078-2006-0-DE-07 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR DE EP 07813497.0 Abandoned
NCI E-317-2002-0-US-07 Molecular Characteristics of Non-Small Cell Lung Cancer US CON 11/829,483 7709202 Expired PDF
NCI E-078-2006-0-PCT-02 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR PCT PCT PCT/US2007/074643 Expired
NCI E-078-2006-0-AU-03 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR AU National Stage 2007278864 Abandoned
NCI E-078-2006-0-CA-04 CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR CA National Stage 2658952 Abandoned
NIBIB E-279-2006-0-US-01 Maxwellian View Photo-simulation/illumination Of Your Discovery For Use With Commercial Fundus Camera US 60/935,107 Abandoned
NCI E-108-2004-1-AU-06 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS AU National Stage 2007277142 Issued
NHGRI E-055-2005-2-US-02 Farnesyl Transferase Inhibitors For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis US ORD 11/828,117 7838531 Abandoned PDF
NIDA E-087-2002-0-US-09 Methods For Treating Cardiac Arrhythmia US CON 11/878,611 7700600 Expired PDF
NCI E-108-2004-1-PCT-02 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS PCT PCT PCT/US2007/016843 Expired
NCI E-108-2004-1-EP-07 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS EP DIV 10014565.5 Abandoned
NCI E-108-2004-1-EP-03 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS EP National Stage 07810823.0 Abandoned
NCI E-108-2004-1-CA-05 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS CA National Stage 2659194 Abandoned
NCI E-292-2001-1-US-03 Use Of Mx GTPase In The Prognosis And Treatment Of Cancer US DIV 11/781,399 Abandoned
NIAID E-109-2007-0-US-01 Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein US 60/961,364 Abandoned
NCI E-061-2007-0-US-01 GENE EXPRESSION PROFILE FOR PREDICTING OVARIAN CANCER PATIENT SURVIVAL US 60/951,073 Abandoned
NCI E-282-2000-0-US-08 Analogs of Thalidomide as Potential Angiogenesis Inhibitors US CON 11/880,404 8716315 Abandoned PDF
NICHD E-096-2004-1-US-01 Multi-purpose Temperature-controlled, Flow-through Miorcel For Anayical Transmission Infared Spectoscopy And Microsopy Of Liquid And Sold Samples US CIP 11/826,806 7894055 Abandoned PDF
NICHD E-183-2005-0-PCT-02 Methods For Conjugation Of Oligosaccharides Or Polysaccharides To Protein Carriers Through Oxime Linkages Via 3-Deoxy-D-Manno-Octulsonic Acid PCT PCT PCT/US2007/016373 Expired
NHLBI E-208-2007-0-US-01 IMIDAZOLIDINONE COMPOUNDS, METHODS TO INHIBIT DEUBIQUITINATION AND METHODS OF TREATMENT US 60/961,202 Abandoned
NCI E-200-1998-0-AU-10 Fitness Assay and Associated Methods AU DIV 2007203321 Expired
NCI E-194-2007-0-US-01 Trifunctional Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging US 60/929,913 Abandoned
NIDDK E-218-2007-1-US-01 A2 Adenosine Receptor Agonists US 60/950,250 Abandoned
NCI E-263-2006-1-EP-03 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA EP National Stage 07799622.1 Issued
NCI E-263-2006-1-DE-04 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA DE EP 07799622.1 Abandoned
NCI E-263-2006-1-FR-05 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA FR EP 07799622.1 Abandoned
NCI E-263-2006-1-GB-06 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA GB EP 07799622.1 Abandoned
NCI E-263-2006-1-IT-07 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA IT EP 07799622.1 Issued
NCI E-263-2006-1-PCT-01 METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA PCT PCT COMB PCT/US2007/073637 Expired